![]() |
The Gerald M. Bowers Endowment Fund for the American Board of Periodontology recently received a pledge of |
CHICAGO – March 18, 2002 – The Bowers Fund for the ABP is a five-year,
“When a donor directs this amount of money to the support of our certification process, it underscores the enormous value of board certification and the standards of excellence it represents. Ultimately, this translates to better oral health for the patients we serve,” says Dr. Jack Caton, chairman of the Bowers Fund campaign.
“Today's periodontal treatments are rapidly advancing,” notes Joe Zack, vice president, sales and marketing for OraPharma. “Educating dental professionals is critical in these changing times. What better culmination of the periodontist's education than to become a diplomate in periodontology? This donation is very much aligned with OraPharma's goal of partnering with the periodontal community and providing easier and more effective treatments for periodontal disease.”
OraPharma, Inc., is a specialty pharmaceutical company that discovers, develops, and commercializes therapeutics for oral health care. The company was founded in 1996 and is headquartered in Warminster, Pennsylvania.
About AAP Foundation: The mission of the American Academy of Periodontology Foundation is to improve the periodontal and general health of the public through increasing public and professional knowledge of periodontal diseases and their therapies, stimulating basic and clinical research to generate new knowledge, and enhancing educational programs at all levels to create opportunities in periodontal education and practice. Periodontics is one of nine dental specialties recognized by the American Dental Association.
To get more information about any AAP Foundation activities, please contact Robert A. Vitas, PhD, CAE, CFRE, Executive Director, at

